Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Cardio_MEMS
gptkb:Harpoon_Medical gptkb:Valtech_Cardio |
| gptkbp:ceo |
gptkb:Michael_A._Mussallem
|
| gptkbp:employees |
~15,000
|
| gptkbp:focus |
critical care
heart disease surgical heart valves transcatheter aortic valve replacement (TAVR) |
| gptkbp:founded |
gptkb:1958
|
| gptkbp:founder |
Miles Edwards
|
| gptkbp:headquarters |
gptkb:Irvine,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Edwards Lifesciences
|
| gptkbp:industry |
gptkb:medical_devices
|
| gptkbp:partnership |
gptkb:Mayo_Clinic
gptkb:University_of_California,_Irvine gptkb:Cleveland_Clinic |
| gptkbp:products |
monitoring systems
heart valves transcatheter heart valves |
| gptkbp:revenue |
$4.5 billion (2022)
|
| gptkbp:stock_symbol |
EW
|
| gptkbp:bfsParent |
gptkb:Liva_Nova
|
| gptkbp:bfsLayer |
5
|